Skip to main content
. 2018 May 1;22(5):537–543. doi: 10.5588/ijtld.17.0697

Table 1.

Participant characteristics of 20 healthy participants in a cross-over study of three formulations containing 600 mg of rifampicin

graphic file with name i1027-3719-22-5-537-t01.jpg